Adamis Pharmaceuticals CEO Dennis Carlo's 2019 pay rises 18% to $1.8M
Adamis Pharmaceuticals reports 2019 executive compensation
By ExecPay News
Published: July 10, 2020
Adamis Pharmaceuticals reported fiscal year 2019 executive compensation information on July 10, 2020.
In 2019, three executives at Adamis Pharmaceuticals received on average a compensation package of $1.5M, a 38% increase compared to previous year.
Dennis J. Carlo, Chief Executive Officer, received $1.8M in total, which increased by 18% compared to 2018. 60.60% of Carlo's compensation, or $1.1M, was in stock awards. Carlo also received $667K in salary and $30.6K in other compensation.
Ronald B. Moss, Chief Medical Officer, received a compensation package of $1.3M, which increased by 61% compared to previous year. 64.07% of the compensation package, or $858.2K, was in stock awards.
Robert O. Hopkins, Chief Financial Officer, earned $1.3M in 2019, a 36% increase compared to previous year.